Vincent Medical (HKG:1612) logged HK$51.6 million in attributable profit for the first half of 2025, up 55% from the HK$33.3 million posted in the year-ago period, according to a Hong Kong bourse filing Wednesday.
Shares of the company closed 1% higher on Thursday.
Basic earnings per share were HK$0.0803, compared with HK$0.0517 in the prior year.
Revenue jumped 18% year-on-year to HK$449.4 million, figures showed.
The company also declared a dividend of HK$0.024, payable Sept. 26 to shareholders of record on Sept. 8.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.